So, Quizartinib is a FLT3 inhibitor used for relapsed or refractory AML that has FLT3-ITD mutations. It basically stops FLT3 signaling. This stuff comes in a tablet form, coated for your convenience.
They offer it in two sizes, 17.7 mg and 26.5 mg. The usual dose is 53 mg per day. But there’s this ramp-up process to get you started.
They pack these tablets up in bottles, each holding 28 pills.
